Tilray Inc (TLRY) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Tilray Inc (TLRY) has a cash flow conversion efficiency ratio of -0.023x as of May 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-37.47 Million) by net assets ($1.59 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see TLRY market cap for the company's overall valuation and market capitalisation.
Tilray Inc - Cash Flow Conversion Efficiency Trend (2012–2026)
This chart illustrates how Tilray Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Tilray Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tilray Inc ranked by their cash flow conversion efficiency. Explore Tilray Inc earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zaptec AS
OL:ZAP
|
0.579x |
|
Nextdoor Holdings Inc
NYSE:KIND
|
0.007x |
|
Regenxbio Inc
NASDAQ:RGNX
|
-0.867x |
|
Elior SCA
PA:ELIOR
|
0.089x |
|
Matrix Concepts Holdings Bhd
KLSE:5236
|
0.037x |
|
Beyond, Inc.
NASDAQ:BYON
|
0.121x |
|
Stendörren Fastigheter AB (publ)
ST:STEF-B
|
0.020x |
|
Kforce Inc.
NASDAQ:KFRC
|
0.177x |
Annual Cash Flow Conversion Efficiency for Tilray Inc (2012–2026)
The table below shows the annual cash flow conversion efficiency of Tilray Inc from 2012 to 2026. View TLRY stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-05-31 | $1.59 Billion | $-69.14 Million | -0.043x | +31.73% |
| 2025-05-31 | $2.04 Billion | $-129.81 Million | -0.064x | -607.55% |
| 2024-05-31 | $4.69 Billion | $-42.11 Million | -0.009x | -609.22% |
| 2023-05-31 | $4.49 Billion | $7.91 Million | 0.002x | +105.57% |
| 2022-05-31 | $5.60 Billion | $-177.26 Million | -0.032x | -161.85% |
| 2021-05-31 | $4.47 Billion | $-53.99 Million | -0.012x | +98.66% |
| 2020-05-31 | $276.54 Million | $-250.16 Million | -0.905x | -286.62% |
| 2019-05-31 | $199.23 Million | $-46.62 Million | -0.234x | -118.91% |
| 2018-05-31 | $-4.76 Million | $-5.89 Million | 1.237x | +194.26% |
| 2017-05-31 | $3.42 Million | $-4.48 Million | -1.313x | -4550.71% |
| 2016-05-31 | $20.61 Million | $-581.74K | -0.028x | +93.08% |
| 2015-05-31 | $8.62 Million | $-3.52 Million | -0.408x | -169.35% |
| 2014-05-31 | $249.75K | $-37.82K | -0.151x | +93.57% |
| 2013-05-31 | $258.27K | $-608.47K | -2.356x | -1723.12% |
| 2012-05-31 | $336.69K | $-43.51K | -0.129x | -- |
About Tilray Inc
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and… Read more